NLRP3 and type 2 diabetes mellitus: Moreover, vildagliptin halted NLRP3 inflammasome activation and decreased IL-1β and IL-18 levels in free fatty acid-induced HUVECs [82].The anti-inflammatory properties of DPP-4i have been shown in different T1DM and T2DM animal models as well.